CAS No. 1029044-16-3
| IUPAC Name | 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridinyl]methyl]pyridin-2-amine | |
|---|---|---|
| CAS Number | 1029044-16-3 | |
| Molecular Formula |
C20H15ClF3N5 |
|
| Molecular Weight (MW) | 417.81 | |
| SMILES | C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F | |
| InChIKey | JGWRKYUXBBNENE-UHFFFAOYSA-N |
Pexidartinib (PLX3397) is an oral multi-targeted receptor tyrosine kinase inhibitor that potently targets colony-stimulating factor 1 receptor (CSF-1R), c-Kit, and FLT3. By blocking CSF-1R signaling, pexidartinib impairs macrophage recruitment and alters tumor-associated macrophage polarization within the tumor microenvironment. This inhibition disrupts cell survival pathways, leading to the induction of apoptosis and necrosis while suppressing tumor growth and progression. [1][2]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
84 mg/mL
(201.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(201.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(201.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
83 mg/mL
(198.65 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(201.04 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- Pexidartinib (PLX3397) Mechanism of Action: CSF1R Inhibition in Synovial Macrophage Research
- Pexidartinib (PLX3397) Clinical Trials
- Pexidartinib (PLX3397): Selectivity & Specificity
- Pexidartinib (PLX3397) Working Concentration | Cell Culture | Treatment
- Pexidartinib (PLX3397) Solubility in DMSO
- Pexidartinib (PLX3397) Stock Solution
- Pexidartinib (PLX3397) Storage
- Pexidartinib (PLX3397) Stability
- Pexidartinib (PLX3397) VS PLX5622
- Pexidartinib (PLX3397) Molecular Weight
- Pexidartinib (PLX3397) SMILES
- Pexidartinib (PLX3397) Chemical Structure (2D and 3D)
- Pexidartinib (PLX3397) IC50 for Cell-based and Cell-free Assays
- Pexidartinib (PLX3397) Sigma (AMBH2D6FF0AB)? Try a better option.
- Pexidartinib (PLX3397) MedChemExpress (HY-16749)? Try a better option.
- Pexidartinib (PLX3397) Cayman (18271)? Try a better option.
- Pexidartinib (PLX3397) Abmole (M4867)? Try a better option.
- Pexidartinib (PLX3397) Tocris (7590)? Try a better option.
- Pexidartinib (PLX3397) SDS|MSDS